Published in J Biol Chem on September 02, 2003
In vitro selection, characterization, and application of deoxyribozymes that cleave RNA. Nucleic Acids Res (2005) 1.51
MNAzymes, a versatile new class of nucleic acid enzymes that can function as biosensors and molecular switches. J Am Chem Soc (2010) 1.19
Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies. Am J Pathol (2007) 1.01
Substrate specificity and kinetic framework of a DNAzyme with an expanded chemical repertoire: a putative RNaseA mimic that catalyzes RNA hydrolysis independent of a divalent metal cation. Nucleic Acids Res (2004) 0.86
Locked nucleoside analogues expand the potential of DNAzymes to cleave structured RNA targets. BMC Mol Biol (2006) 0.84
Mismatch Discrimination and Efficient Photomodulation with Split 10-23 DNAzymes. Inorganica Chim Acta (2012) 0.81
Coarse-Grained Brownian Dynamics Simulations of the 10-23 DNAzyme. Biophys J (2009) 0.81
Artificial DNA and surface plasmon resonance. Artif DNA PNA XNA (2012) 0.77
Biochemical and Biophysical Understanding of Metal Ion Selectivity of DNAzymes. Inorganica Chim Acta (2016) 0.77
A novel dengue virus detection method that couples DNAzyme and gold nanoparticle approaches. Virol J (2013) 0.75
A smart ZnO@polydopamine-nucleic acid nanosystem for ultrasensitive live cell mRNA imaging by the target-triggered intracellular self-assembly of active DNAzyme nanostructures. Chem Sci (2017) 0.75
Bleeding complications and liver injuries during phenprocoumon treatment: a multicentre prospective observational study in internal medicine departments. Dtsch Arztebl Int (2013) 2.37
Automated 3D structure composition for large RNAs. Nucleic Acids Res (2012) 1.85
RNA FRABASE 2.0: an advanced web-accessible database with the capacity to search the three-dimensional fragments within RNA structures. BMC Bioinformatics (2010) 1.41
RNA FRABASE version 1.0: an engine with a database to search for the three-dimensional fragments within RNA structures. Nucleic Acids Res (2007) 1.33
Interaction and functional association of protein disulfide isomerase with alphaVbeta3 integrin on endothelial cells. FEBS J (2008) 1.09
The bulge region of HIV-1 TAR RNA binds metal ions in solution. Nucleic Acids Res (2002) 1.08
Lumican inhibits angiogenesis by interfering with α2β1 receptor activity and downregulating MMP-14 expression. Thromb Res (2011) 1.03
Bulged adenosine influence on the RNA duplex conformation in solution. Biochemistry (2008) 1.01
Thymosin beta 4 induces the synthesis of plasminogen activator inhibitor 1 in cultured endothelial cells and increases its extracellular expression. Blood (2003) 1.00
Mast cell-derived exosomes activate endothelial cells to secrete plasminogen activator inhibitor type 1. Arterioscler Thromb Vasc Biol (2005) 1.00
Inducible heat shock protein 70 promotes myelin autoantigen presentation by the HLA class II. J Immunol (2004) 0.96
The apical loop of the HIV-1 TAR RNA hairpin is stabilized by a cross-loop base pair. J Biol Chem (2003) 0.95
RNAlyzer--novel approach for quality analysis of RNA structural models. Nucleic Acids Res (2013) 0.95
The in vitro loose dimer structure and rearrangements of the HIV-2 leader RNA. Nucleic Acids Res (2011) 0.94
Ero1alpha is expressed on blood platelets in association with protein-disulfide isomerase and contributes to redox-controlled remodeling of alphaIIbbeta3. J Biol Chem (2010) 0.94
Heat shock proteins and other components of cellular machinery for protein synthesis are up-regulated in vascular endothelial cell growth factor-activated human endothelial cells. Proteomics (2005) 0.89
The specificity and function of the metal-binding sites in the integrin beta3 A-domain. J Biol Chem (2006) 0.89
DNAzymes to beta 1 and beta 3 mRNA down-regulate expression of the targeted integrins and inhibit endothelial cell capillary tube formation in fibrin and matrigel. J Biol Chem (2001) 0.87
New, extended hairpin form of the TAR-2 RNA domain points to the structural polymorphism at the 5' end of the HIV-2 leader RNA. Nucleic Acids Res (2006) 0.87
[Analysis of hospital admissions associated with digitalis glycosides]. Med Klin (Munich) (2007) 0.84
Identification and characterization of two cation binding sites in the integrin beta 3 subunit. J Biol Chem (2002) 0.84
High-throughput method for the prediction of low-resolution, three-dimensional RNA structures. Nucleic Acids Symp Ser (Oxf) (2006) 0.84
Protein disulfide isomerase directly interacts with β-actin Cys374 and regulates cytoskeleton reorganization. J Biol Chem (2014) 0.83
Induction of PAI-1 expression by tumor necrosis factor alpha in endothelial cells is mediated by its responsive element located in the 4G/5G site. FEBS J (2005) 0.83
High salt solution structure of a left-handed RNA double helix. Nucleic Acids Res (2004) 0.83
Binding of PAI-1 to endothelial cells stimulated by thymosin beta4 and modulation of their fibrinolytic potential. J Biol Chem (2005) 0.83
Autocrine effects of VEGF-D on endothelial cells after transduction with AD-VEGF-D(DeltaNDeltaC). Exp Cell Res (2010) 0.82
ARCS: an aggregated related column scoring scheme for aligned sequences. Bioinformatics (2006) 0.82
Association of plasminogen activator inhibitor type 2 (PAI-2) with proteasome within endothelial cells activated with inflammatory stimuli. J Biol Chem (2011) 0.82
Fibrinogen contains cryptic PAI-1 binding sites that are exposed on binding to solid surfaces or limited proteolysis. Arterioscler Thromb Vasc Biol (2005) 0.81
Ku80 as a novel receptor for thymosin beta4 that mediates its intracellular activity different from G-actin sequestering. J Biol Chem (2007) 0.81
Noncanonical G(syn)-G(anti) base pairs stabilized by sulphate anions in two X-ray structures of the (GUGGUCUGAUGAGGCC) RNA duplex. RNA (2008) 0.81
The HIV-2 TAR RNA domain as a potential source of viral-encoded miRNA. A reconnaissance study. Nucleic Acids Symp Ser (Oxf) (2008) 0.81
Matrin 3 as a key regulator of endothelial cell survival. Exp Cell Res (2010) 0.81
Tolerability of beta-blockers metabolized via cytochrome P450 2D6 is sex-dependent. Clin Pharmacol Ther (2006) 0.80
Secretion of SerpinB2 from endothelial cells activated with inflammatory stimuli. Exp Cell Res (2013) 0.79
Plasminogen activator inhibitor type 1 interacts with alpha3 subunit of proteasome and modulates its activity. J Biol Chem (2010) 0.78
Cardiovascular effects, pharmacokinetics and cross-reactivity in digitalis glycoside immunoassays of an antidiarrheal uzara root extract. Int J Clin Pharmacol Ther (2012) 0.78
Function-stabilizing mechanism of plasminogen activator inhibitor type 1 induced upon binding to alpha1-acid glycoprotein. Biochemistry (2005) 0.78
Thymosin β4 promotes the migration of endothelial cells without intracellular Ca2+ elevation. Exp Cell Res (2012) 0.77
Pharmacokinetics and safety of a novel anti-HBs-enriched immunoglobulin in healthy volunteers after subcutaneous and intramuscular administration. Eur J Clin Pharmacol (2006) 0.76
The molecular dynamics thermocycler. A new approach to sample conformational space, as exemplified by the RNA hairpin. Nucleic Acids Res Suppl (2002) 0.75
Interleukin 6 deficiency affects spontaneous activity of mice in age- and sex-dependent manner. Acta Neurobiol Exp (Wars) (2014) 0.75
Re: Age- and gender-specific incidence of hospitalisation for digoxin intoxication. Drug Saf (2007) 0.75
Cerivastatin, a HMG-CoA reductase inhibitor, reduces plasminogen activator inhibitor-1 (PAI-1) expression in endothelial cells by down-regulation of cellular signaling and the inhibition of PAI-1 promoter activity. Jpn J Pharmacol (2002) 0.75
Intraprocedural reduction of the veno-arterial norepinephrine gradient correlates with blood pressure response after renal denervation. EuroIntervention (2015) 0.75
Inhibition of ADP-triggered blood platelet aggregation by diadenosine polyphosphate analogues. Bioorg Med Chem Lett (2002) 0.75